The Michael J. Fox Foundation for Parkinson’s Research and the Center for the Advancement of Science in Space yesterday inked a collaboration to send a protein linked to Parkinson’s disease to the International Space Station. The researchers plan to evaluate the protein’s growth under microgravity conditions, which could foster larger, more regular LRRK2 protein crystals […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
FDA recalls Penumbra 3D Revascularization device over wire separation issues
The FDA today released a recall notice for Penumbra‘s (NYSE:PEN) 3D Revascularization Device, part of its Penumbra system designed to remove thrombus from brain blood vessels during strokes, over issues with wire breaks and separations. The FDA labeled the recall as Class I, its most serious designation, indicating that there is a reasonable probability that use […]
Report: Pipeline of Alzheimer’s drugs ‘due for big victories’ in next 5 years
There are twenty-seven Alzheimer’s drugs in late-stage clinical trials and eight candidates in Phase II programs that could launch in the next 5 years, according to an analysis presented this week at the Alzheimer’s Association International Conference. “The Alzheimer’s disease pipeline, marred by decades of failures and underinvestment, is due for big victories,” UsAgainstAlzheimer’s co-founder […]
Epilepsy biomarker could aid in early detection, targeted treatment
Researchers from the University of Illinois at Chicago College of Medicine have identified a unique chemical biomarker associated with epileptic brain tissue, according to an article published in the journal Epilepsia. The chemical signature can be detected noninvasively and could enable physicians to precisely locate small regions of abnormal brain tissue in early-stage patients. The researchers […]
Rapid Medical raises $9m in Series B for neurovascular devices
Neurovascular device maker Rapid Medical said today it closed a $9 million Series B round of financing to support its minimally invasive stroke treatment and prevention devices. Rapid Medical produces the Tigertriever revascularization device and Comaneci adjustable remodeling mesh designed for neurovascular use, the Israel-based company said. The company touted the Tigertriever as the only […]
Corium touts clinical data for transdermal delivery of Alzheimer’s drug
Corium (NSDQ:CORI) touted data today from a pilot bioequivalence study, comparing its Corplex Donepezil transdermal patch to oral Aricept as delivery method for the most commonly prescribed treatment for Alzheimer’s disease. Data from the pilot study demonstrated that Corium’s transdermal patch met the criteria for bioequivalence to oral Aricept, as measured by primary pharmacokinetic endpoints previously […]
Study: Nanomedicine shuts down cells that drive cancer growth in glioblastoma
Researchers from Northwestern Medicine have developed lipid polymer-based nanoparticles that target key cancer drivers, called brain tumor initiating cells, in a mouse model of glioblastoma brain tumors. “BTICs are malignant brain tumor populations that underlie the therapy resistance, recurrence and unstoppable invasion commonly encountered by glioblastoma patients after the standard treatment regimen of surgical resection, radiation and […]
Elekta taps Brainlab as select EU distro partner for stereotactic neuro devices
Elekta (STO:EKTA B) said today it tapped Brainlab to distribute its stereotactic neurological devices across select markets in the European Union. The distribution agreement covers Elekta’s Leksell Vantage Steretactic target localization and coordinate referencing neurosurgery system, the company said, which received CE Mark approval in the EU in March. The device is currently pending 510(k) clearance […]
Study: Researchers develop new spectroscopy probe, claim 100% cancer detection rate
Researchers at the University of Montreal Hospital Research Center say they have developed a multimodal optical spectroscopy probe that could provide patients with common widespread forms of cancer longer life expectancies and lower risk of recurrence. The team, which began work on the probe in 2015, have refined the invention and designed a new device […]
Researchers make steps towards closed-loop DBS system for essential tremor, Parkinsons
Researchers at the University of Washington say they developed an advanced deep brain stimulation system designed to treat essential tremor without constantly being “on,” allowing for longer battery life and better treatment. The system utilizes electrodes on top of the brain to sense movement in parts of the body that experience essential tremor, alongside a […]
Neuroimaging could be the key to early autism diagnoses
Functional connectivity magnetic resonance imaging (fcMRI) may be able to predict the chances of developing autism by the age of 2 in high-risk 6-month old infants, according to a new study in the Science Translational Medicine journal. Autism is characterized by challenges in social skills, repetitive behaviors, speech and nonverbal communication. People with autism also […]